Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Curr Treat Options Psychiatry. 2014 Mar 22;1(2):107–120. doi: 10.1007/s40501-014-0010-9

TABLE 1.

Currently available antipsychotic medications (From [39, 48]

Compound Trade name CPZ
equiv
Dose
(mg/d)
Maintenance (mg/d)
First generation (FGA)
Fluphenazine Prolixin 2 6–20 6–12
Trifluperazine Stelazine 15–50 15–30
Perphenazine Trilafon 10 30–100 30–60
Mesoridazine Serentil 50 150–400 150–300
Chlorpromazine Thorazine 100 300–1000 300–600
Thioridazine Navane 100 300–800 300–600
Haloperidol Haldol 2 6–20 6–12
Thiothixene Navane 5 15–50 15–30
Molindone Moban 10 30–100 30–60
Loxapine Loxitane 10 30–100 30–60
Second generation (SGA)
Clozapine Clozaril 150–600 150–600
Risperidone Risperidal 2–8 2–8
Paliperidone Invega 3–15 3–15
Olanzapine Zyprexa 10–20 10–20
Quetiapine Seroquel 300–750 300–750
Ziprasidone Geodon 120–160 80–160
Aripiprazole Abilify 10–30 10–30
Asenapine Sepharis 10–20 10–20
Iloperidone Fanapt 12–24 12–24
Lurasidone Latuda 40–160 40–160
Cariprazine 1.5–12 1.5–9
Long acting injectables (LAI)
Fluphenazine decanoate Modecate 12.5–25 12.5–100 (/2 wks)
Haloperidol decanoate Haldol 100 100–450 (/4 wks)
Risperidone microspheres Risperidol consta 251 25–50 (/2 wks)
Paliperidone palmitate Invega Sustenna 234 day 1; 156, day 7 39–234 (/4 wks)
Olanzapine pamoate Zyprexa Relprevv 300 300 (/2 wks)
Aripiprazole suspension Abilify Maintena 4002 300–400 (monthly)
1

supplemental oral medication needed × 3 wks;

2

supplemental oral medication needed × 2 wks